Estradiol Promotion of Size and Number of Hepatic Enzyme-Altered Foci in Rats in the Absence of Cell Proliferation
High-dose (95 μg/kg/day) 17β-estradiol (E2) administered as a promoter in a two-stage model of hepatocarcinogenesis significantly (p < 0.05) increases the number, size (mean volume and mean surface area) and volume density of enzyme-altered foci (EAF) larger than 0.003 mm2 in the livers of ovariectomized F344 rats when compared with diethylnitrosamine-initiated (150 mg/kg) controls. Changes observed at 9.5 μg E2/kg/day, which mimics serum E2 levels of intact animals, were limited to a qualitative increase in the number of EAF ≤ 0.003 mm2. At termination (days 39/40), the mean cumulative bromodeoxyuridine (BrdU) labeling indices for the E2-treated groups did not differ from the mean labeling index for initiated controls. E2’s failure to increase the cumulative BrdU-labeling index indicates that generalized hepatic growth stimulation (proliferation as measured by BrdU-labeling index) does not completely explain the increase in number and/or size of EAF observed. It is hypothesized that an alteration of the cell-cycle kinetics of initiated hepatic EAF may contribute to the promotion of hepatocarcinogenesis by E2.
KeywordsEstrogen Sodium Chloride Tamoxifen Estradiol Choline
Unable to display preview. Download preview PDF.
- 1.Huggins GR, Zucker PK (1987) Oral contraceptives and neoplasia: 1987 update. Fert and Steril 47:733–761.Google Scholar
- 5.Campen DB, Sloop TC, Maronpot RR, Lucier GW (1987) Continued development of hepatic y-glutamyltranspeptidase-positive foci upon withdrawal of 17 cc-ethynyl estradiol in diethylnitrosamine-initiated rats. Cancer Res 47:228–2333.Google Scholar
- 6.Tritscher AM, Clark GC, Lin, FH, Lucier GW (1992) Ovarian hormones enhance the carcinogenic activity of 2,3,7,8-TCDD in rats. In Li JJ, Nandi S, Li SA (eds): Hormonal Carcinogenesis. New York: Springer-Verlag, pp 326–329.Google Scholar
- 8.Gunzel P, Putz B, Lehmann M, Hasan SH, et al. (1989) Steroid toxicology and the “pill”: Comparative aspects of experimental test systems and the human. In Day an AD and Paine A J (eds): Advances in Applied Toxicology. New York: Taylor and Francis, Ltd, pp 19–49.Google Scholar